✦ LIBER ✦

Sensitive serum markers for detecting pancreatic cancer

✍ Scribed by Tetsuo Hayakawa; Takaharu Kondo; Tokimune Shibata; Hirotsugu Hamano; Motoji Kitagawa; Yuzo Sakai; Hideki Ono

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 467 KB
Volume: 61
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880501)61:9<1827::aid-cncr2820610918>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blood and serum substances for markers o

Blood and serum substances for markers of prostate cancer

✍ Chris H. Bangma; Paul C.M.S. Verhagen 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Plasma ribonuclease. A marker for the de

Plasma ribonuclease. A marker for the detection of ovarian cancer

✍ Dr. Bertrum Sheid; Therese Lu; Lauri Pedrinan; James H. Nelson Jr. 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 1 views

Ovarian cancer screening. The use of ser

Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection

✍ Jonathan S. Berek; Robert C. Bast 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

Usefulness of a new tumor marker, span-1

Usefulness of a new tumor marker, span-1, for the diagnosis of pancreatic cancer

✍ Seiki Kiriyama; Tetsua Hayakawa; Takaharu Kando; Tokimune Shibata; Motoji Kitaga 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 1 views

Serum neuron-specific enolase is a usefu

Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer

✍ O. C. Burghuber; B. Worofka; G. Schernthaner; N. Vetter; M. Neumann; R. Dudczak; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 1 views

Genetic markers for early detection of l

Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention

✍ Wiest, Jonathan S.; Franklin, Wilbur A.; Drabkin, Harry; Gemmill, Robert; Sidran 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Lung cancer is one of the leading causes of cancer death in the world. The high mortality rate for lung cancer probably results, at least in part, from the absence of standard clinical procedures for diagnosis of the disease at early and more treatable stages compared to breast, prostate, and colon